Systemic metabolic alterations and their relationship to neuropsychiatric symptomatology PAIS, including long COVID, as well as CFS and IMD, share the characteristic of systemic metabolic disturbances, which may be a sign of underlying multi-organ inflammation and exhaustion [31], and consequently may contribute to neuropsychiatric symptomatology, as many metabolites can cross the bloodbrain barrier (BBB) [30, 58] (e.g., short chain fatty acids (SCFAs) derived from the gut microbiota such as acetate [40], amino acids such as tryptophan [52] and also carnitine/acetylcarnitine can cross the BBB via transporters [59])
Li, X., Wang, Y., & Zhao, H
Uma estrutura voltada a parcerias com a comunidade cientfica, profissionais de sade e instituies, para acelerar solues e transformar vidas.
Earlier, you will see hydration and surface texture
Free Radic Biol Med 211, 171-173
No, it is based on preclinical evidence and user practice rather than human clinical trials